RxDoctor Payments Data

Sarah Lewis, DO

Family Medicine · Sturgis, SDNPI 1124581384

Payments from drug & device makers

$380in general payments, 2019–2025

Across 21 payments — averaging $18.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$112
  • AbbVie$75
  • Novo Nordisk$32
  • Amneal Pharmaceuticals LLC$28
  • Boston Scientific$24
  • Pfizer$18
  • plus $91 from 6 others

What the payments were for

  • Food & beverage$380100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$380 in reported general payments places this provider in the 60th percentile of 408 family medicine providers in South Dakota.

See all family medicine providers in South Dakota

Medicare billing

Part B allowed, 2024
$16,551
Medicare patients
116
Services billed
188

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban132$175,622
JardianceEmpagliflozin57$69,020
TrulicityDulaglutide27$41,987
XareltoRivaroxaban29$38,406
MounjaroTirzepatide26$25,202
Soliqua 100-33Insulin Glargine/Lixisenatide23$23,484
RybelsusSemaglutide14$16,414
Tresiba Flextouch U-200Insulin Degludec13$16,312
OzempicSemaglutide15$14,708
Repatha SureclickEvolocumab14$12,900
Spiriva RespimatTiotropium Bromide12$10,894
Trelegy ElliptaFluticasone/Umeclidin/Vilanter15$10,648
Breo ElliptaFluticasone/Vilanterol16$9,798
MyrbetriqMirabegron15$9,470
JanuviaSitagliptin Phosphate16$8,786

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$18$175,622132 claims
Lilly USA, LLCTrulicity, Mounjaro$16$67,18953 claims
Novo NordiskRybelsus, Ozempic$32$31,12229 claims
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Shingrix$13$28,45854 claims
MerckJanuvia$18$8,78616 claims
AbbVieSynthroid$75$3,22333 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$28$3,004245 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 408 family medicine providers in South Dakota.

Other family medicine in Sturgis

See the full list for South Dakota

Where these figures come from

Is this you, or does something look wrong? →